Transplant Clinical Trials

736 recruitingLast updated: June 18, 2026

There are 736 actively recruiting transplant clinical trials across 53 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Phase 4, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Houston, Texas, United States. Updated daily from ClinicalTrials.gov.


Transplant Trials at a Glance

736 actively recruiting trials for transplant are listed on ClinicalTrialsFinder across 6 cities in 53 countries. The largest study group is Not Applicable with 213 trials, with the heaviest enrollment activity in Boston, New York, and Houston. Lead sponsors running transplant studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Assistance Publique - Hôpitaux de Paris, and Mayo Clinic.

Treatments under study

About Transplant Clinical Trials

Looking for clinical trials for Transplant? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Transplant trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Transplant clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 736 trials

Recruiting
Phase 4

Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation

Acute Kidney InjuryLiver Transplantation
Rennes University Hospital400 enrolled8 locationsNCT06535945
Recruiting
Phase 2

Ivosidenib as Post-HSCT Maintenance for AML

Acute Myeloid Leukemia (AML)IDH1 MutationHematopoietic Stem Cell Transplant (HSCT)
Massachusetts General Hospital75 enrolled5 locationsNCT06707493
Recruiting

Access to Kidney Transplant of Obese Patients Beginning Dialysis

Obese PatientsComorbiditiesDialysis+1 more
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04748770
Recruiting
Not Applicable

Rectus-Intercostal Fascial Plane Block for Liver Transplantation Donors

Postoperative PainLiver TransplantationLiving Donor
Istinye University64 enrolled1 locationNCT07233096
Recruiting

The Mycophenolate Pregnancy Registry

Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune Diseases
Genentech, Inc.500 enrolled1 locationNCT01733082
Recruiting

Response to Influenza Vaccination in Pediatric Oncology Patients

Hematologic MalignancyPediatric CancerTransplant-Related Cancer
St. Jude Children's Research Hospital150 enrolled1 locationNCT05384288
Recruiting

GRAfT 2.0. A Multimodal Prospective Approach to Define the Mechanisms and Clinical Features of Acute and Chronic Rejection in Lung Transplantation

end stage lung diseaseLung TransplantRejection
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT07516379
Recruiting
Phase 1Phase 2

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell Transplantation
National Cancer Institute (NCI)260 enrolled2 locationsNCT05436418
Recruiting
Phase 2

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation
Children's Hospital Medical Center, Cincinnati60 enrolled1 locationNCT05501756
Recruiting
Phase 3

Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients

Cytomegalovirus InfectionsKidney Transplant InfectionPancreas Transplant
University of Wisconsin, Madison90 enrolled1 locationNCT06407232
Recruiting

Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

Kidney Transplant Rejection
Virginia Commonwealth University50 enrolled1 locationNCT07415876
Recruiting
Phase 2

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients

HypophosphatemiaKidney Transplantation
Stanford University90 enrolled1 locationNCT06824454
Recruiting

Development of a Mobile Terminal-Based Intelligent Detection System for Multiple Anterior Segment Diseases of the Eye

pterygiumCataractBlepharitis+13 more
Zhongshan Ophthalmic Center, Sun Yat-sen University3,000 enrolled1 locationNCT07634913
Recruiting
Not Applicable

A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients

Hair TransplantationScalp CareSeborrheic Dermatitis
ChinaNorm120 enrolled1 locationNCT07641686
Recruiting
Phase 2

Tocilizumab in Lung Transplantation

Lung Transplant
National Institute of Allergy and Infectious Diseases (NIAID)350 enrolled21 locationsNCT06033196
Recruiting
Early Phase 1

Tolerance Through Mixed Chimerism (Sip-Tego)

Kidney FailureTransplant Recipient (Kidney)Immunosuppresion+2 more
Tatsuo Kawai, MD, PhD12 enrolled1 locationNCT06972069
Recruiting
Phase 2

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

Liver Transplant
National Institute of Allergy and Infectious Diseases (NIAID)100 enrolled10 locationsNCT07549503
Recruiting
Not Applicable

Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney Transplant (COMPKT) Program

ObesityKidney Transplant; Complications
Virginia Commonwealth University30 enrolled1 locationNCT06688825
Recruiting
Not Applicable

The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation

Renal Transplantation
Akdeniz University56 enrolled1 locationNCT07294183
Recruiting
Phase 3

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients

Kidney Transplant Failure and RejectionBK ViremiaKidney Transplant Infection
The University of Queensland280 enrolled13 locationsNCT05325008